Plain-language summary
Researchers isolated exosomes from adipose-derived mesenchymal stem cells and tested them in a mouse model of lipopolysaccharide-induced acute lung injury. Treated animals kept a more intact alveolar architecture, with lower lung injury scores and less pulmonary oedema. The effect traced to a single microRNA cargo, miR-19b-3p, which the vesicles delivered into macrophages; it targets TGFBR2 and quiets TGFBR2/Smad4 signalling, which in turn lowers NLRP3 transcription and pulls macrophages away from the pro-inflammatory M1 state and away from pyroptosis. Silencing miR-19b-3p, or forcing Smad4 or NLRP3 expression, cancelled the protection, which is what makes the proposed pathway credible rather than merely correlative.
Key findings
- Adipose-derived MSC exosomes improved alveolar architecture, lung injury scores and the lung wet-to-dry ratio in an LPS-induced acute lung injury mouse model.
- Both in vivo and in vitro the vesicles suppressed M1 macrophage polarisation and macrophage pyroptosis, and reduced apoptosis of alveolar epithelial cells.
- The identified cargo is miR-19b-3p, which targets TGFBR2 and attenuates TGFBR2/Smad4 signalling in recipient macrophages.
- Weaker Smad4 signalling lowered transcription of NLRP3, the inflammasome node that sustains M1 polarisation and pyroptosis.
- Inhibiting miR-19b-3p, or over-expressing Smad4 or NLRP3, abolished the protective effect, supporting the proposed axis.
- This is preclinical work in mice and cell culture; it does not establish clinical benefit in humans.
Why this matters for lung repair
Acute lung injury is driven largely by a self-amplifying macrophage response rather than by the original trigger, so agents that re-programme macrophage behaviour have long been a research target. This paper is useful because it follows one complete route, from vesicle cargo to receptor to inflammasome, and then tests each link, which is the standard of evidence the field needs before any translational claim is made. The study is preclinical, and JuvGuard references it for scientific education only.
Original abstract
Objective: This study investigated whether adipose-derived mesenchymal stem cells-exosomes (ADMSC-Exo) alleviate lipopolysaccharide (LPS)-induced acute lung injury (ALI) by regulating NLRP3 inflammasome-mediated macrophage M1 polarization and pyroptosis through the miR-19b-3p/TGFBR2/Smad4 signaling axis. Methods: An LPS-induced mouse model of ALI was established and treated with ADMSC-Exo or adenoviral TGFBR2 overexpression (Ad-TGFBR2). Lung histopathology, lung wet-to-dry (W/D) weight ratio, macrophage polarization, and pyroptosis were evaluated. In vitro, macrophages with TGFBR2 knockdown or overexpression were stimulated with LPS and treated with ADMSC-Exo. Lung epithelial cells were subsequently cultured with macrophage-conditioned medium. The expression of miR-19b-3p, TGFBR2, mothers against decapentaplegic homolog 4 (Smad4), and NOD-like receptor protein 3 (NLRP3), together with macrophage polarization, pyroptosis, and epithelial cell apoptosis, was assessed. Predicted molecular interactions were validated using bioinformatic analyses and the JASPAR database. Results: ADMSC-Exo alleviated LPS-induced lung injury by preserving alveolar architecture and reducing lung injury scores and the W/D ratio. They inhibited M1 macrophage polarization and pyroptosis both in vivo and in vitro, thereby decreasing apoptosis of lung epithelial cells. Mechanistically, ADMSC-Exo-delivered miR-19b-3p, which targeted TGFBR2 and inhibited TGFBR2/Smad4 signaling, resulting in transcriptional suppression of NLRP3 expression. Inhibition of miR-19b-3p or overexpression of Smad4/NLRP3 partially abolished the protective effects of ADMSC-Exo. Collectively, ADMSC-Exo attenuated LPS-induced ALI by suppressing NLRP3-mediated macrophage M1 polarization and pyroptosis through the miR-19b-3p/TGFBR2/Smad4 signaling axis. Conclusion: ADMSC-derived exosomes alleviate LPS-induced acute lung injury by delivering miR-19b-3p to inhibit the TGFBR2/Smad4 signaling pathway, thereby suppressing NLRP3-mediated macrophage M1 polarization and pyroptosis and reducing lung epithelial cell apoptosis.
Frequently asked questions
What did this study find?
Researchers isolated exosomes from adipose-derived mesenchymal stem cells and tested them in a mouse model of lipopolysaccharide-induced acute lung injury. Treated animals kept a more intact alveolar architecture, with lower lung injury scores and less pulmonary oedema. The effect traced to a single microRNA cargo, miR-19b-3p, which the vesicles delivered into macrophages; it targets TGFBR2 and quiets TGFBR2/Smad4 signalling, which in turn lowers NLRP3 transcription and pulls macrophages away from the pro-inflammatory M1 state and away from pyroptosis. Silencing miR-19b-3p, or forcing Smad4 or NLRP3 expression, cancelled the protection, which is what makes the proposed pathway credible rather than merely correlative.
Was this tested in humans or in the laboratory?
This is preclinical work — the findings come from laboratory models, not from human participants.
Where can I read the original paper?
The full text lives with the publisher: https://doi.org/10.3389/fimmu.2026.1739115
Does this study prove that JuvGuard works?
No. This is an independent, peer-reviewed study on extracellular vesicles. JuvGuard references the published literature for education only. A single paper cannot establish that any product works, and nothing here is medical advice.
How to cite this paper
Li Jie, Kang Huan, Wang Baolong, Zou Fangqiang, Liu Wei, Guo Weixin et al.. Adipose-derived mesenchymal stem cell-exosomes attenuate lipopolysaccharide-induced acute lung injury in mice by regulating the TGFBR2/Smad4 axis to suppress NLRP3-mediated macrophage M1 polarization and pyroptosis.. Frontiers in immunology. 2026, 2026-09-29. DOI: 10.3389/fimmu.2026.1739115
Source & verification
- Journal: Frontiers in immunology
- Published: 29 September 2026
- DOI: 10.3389/fimmu.2026.1739115
- PubMed ID: 42807288
- Indexed via: pubmed
- MeSH terms: Animals, Acute Lung Injury, Smad4 Protein, Mice, Lipopolysaccharides, NLR Family, Pyrin Domain-Containing 3 Protein, Receptor, Transforming Growth Factor-beta Type II, Pyroptosis, Mesenchymal Stem Cells, Signal Transduction, Macrophages, Male